Bristol Myers Squibb (CELG-RI) Treasury Shares (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of Treasury Shares data on file, last reported at $43.5 billion in Q1 2026.

• Treasury Shares for Q1 2026 came in at $43.5 billion, changed 0.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.5 billion (changed 0.19% YoY), and the FY2025 annual result was $43.6 billion, changed 0.17% from the prior year.
• Treasury Shares held at $43.5 billion in Q1 2026 per CELG-RI's latest filing, from $43.6 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $902.0 million in Q4 2023 and troughed at $12.0 million in Q3 2022.
• A 5-year average of $767.4 million and a median of $887.0 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares increased 29.37% in 2022, then retreated 0.25% in 2024.
• A 5-year view of Treasury Shares shows it stood at $38.6 billion in 2022, then gained by 13.33% to $43.8 billion in 2023, then fell by 0.25% to $43.7 billion in 2024, then declined by 0.17% to $43.6 billion in 2025, then retreated by 0.15% to $43.5 billion in 2026.
• Business Quant data shows CELG-RI's Treasury Shares at $43.5 billion in Q1 2026, $43.6 billion in Q4 2025, and $43.6 billion in Q3 2025.